|
1
|
Grady WM and Markowitz SD: Genetic and
epigenetic alterations in colon cancer. Annu Rev Genomics Hum
Genet. 3:101–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garber JE and Offit K: Hereditary cancer
predisposition syndromes. J Clin Oncol. 23:276–292. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jasperson KW, Tuohy TM, Neklason DW and
Burt RW: Hereditary and familial colon cancer. Gastroenterology.
138:2044–2058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oliveira C, Seruca R and Carneiro F:
Genetics, pathology, and clinics of familial gastric cancer. Int J
Surg Pathol. 14:21–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Entius MM, Keller JJ, Westerman AM, van
Rees BP, van Velthuysen ML, de Goeij AF, Wilson JH, Giardiello FM
and Offerhaus GJ: Molecular genetic alterations in hamartomatous
polyps and carcinomas of patients with Peutz-Jeghers syndrome. J
Clin Pathol. 54:126–131. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torrezan GT, da Silva FC, Santos EM,
Krepischi AC, Achatz MI, Aguiar S Jr, Rossi BM and Carraro DM:
Mutational spectrum of the APC and MUTYH genes and
genotype-phenotype correlations in Brazilian FAP, AFAP, and MAP
patients. Orphanet J Rare Dis. 8:542013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Attard TM, Abraham SC and Cuffari C: The
clinical spectrum of duodenal polyps in pediatrics. J Pediatr
Gastroenterol Nutr. 36:116–119. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aarnio M, Sankila R, Pukkala E, Salovaara
R, Aaltonen LA, de la Chapelle A, Peltomäki P, Mecklin JP and
Järvinen HJ: Cancer risk in mutation carriers of
DNA-mismatch-repair genes. Int J Cancer. 81:214–218. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rowley PT: Inherited susceptibility to
colorectal cancer. Annu Rev Med. 56:539–554. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stoffel E, Mukherjee B, Raymond VM, Tayob
N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S and
Gruber SB: Calculation of risk of colorectal and endometrial cancer
among patients with Lynch syndrome. Gastroenterology.
137:1621–1627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lynch HT, Lynch PM, Lanspa SJ, Snyder CL,
Lynch JF and Boland CR: Review of the Lynch syndrome: history,
molecular genetics, screening, differential diagnosis, and
medicolegal ramifications. Clin Genet. 76:1–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Douglas JA, Gruber SB, Meister KA, Bonner
J, Watson P, Krush AJ and Lynch HT: History and molecular genetics
of Lynch syndrome in family G: a century later. JAMA.
294:2195–2202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lynch HT and de la Chapelle A: Hereditary
colorectal cancer. N Engl J Med. 348:919–932. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lynch HT and Lynch J: Lynch syndrome:
genetics, natural history, genetic counseling, and prevention. J
Clin Oncol. 18:(Suppl 21). 19S–31S. 2000.PubMed/NCBI
|
|
15
|
Gruber SB: New developments in Lynch
syndrome (hereditary nonpolyposis colorectal cancer) and mismatch
repair gene testing. Gastroenterology. 130:577–587. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu KH and Broaddus RR: Gynecologic cancers
in lynch syndrome/hnpcc. Fam Cancer. 4:249–254. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hampel H, Frankel W, Panescu J, Lockman J,
Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA,
et al: Screening for Lynch syndrome (hereditary nonpolyposis
colorectal cancer) among endometrial cancer patients. Cancer Res.
66:7810–7817. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eng C, Hampel H and de la Chapelle A:
Genetic testing for cancer predisposition. Annu Rev Med.
52:371–400. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lindor NM, Petersen GM, Hadley DW, Kinney
AY, Miesfeldt S, Lu KH, Lynch P, Burke W and Press N:
Recommendations for the care of individuals with an inherited
predisposition to Lynch syndrome: a systematic review. JAMA.
296:1507–1517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peltomäki P: Lynch syndrome genes. Fam
Cancer. 4:227–232. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vasen HF: Clinical description of the
Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].
Fam Cancer. 4:219–225. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hampel H and Peltomaki P: Hereditary
colorectal cancer: risk assessment and management. Clin Genet.
58:89–97. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lynch HT and Smyrk T: Hereditary
nonpolyposis colorectal cancer (Lynch syndrome). An updated review.
Cancer. 78:1149–1167. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lynch HT, Smyrk T and Lynch JF: Molecular
genetics and clinical-pathology features of hereditary nonpolyposis
colorectal carcinoma (Lynch syndrome): historical journey from
pedigree anecdote to molecular genetic confirmation. Oncology.
55:103–108. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guillem JG, Wood WC, Moley JF, Berchuck A,
Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, et
al: ASCO; SSO: ASCO/SSO review of current role of risk-reducing
surgery in common hereditary cancer syndromes. J Clin Oncol.
24:4642–4660. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lynch HT and Lynch JF: What the physician
needs to know about Lynch syndrome: an update. Oncology (Williston
Park). 19:455–463; discussion 463–454, 466, 469. 2005.PubMed/NCBI
|
|
27
|
Ribic CM, Sargent DJ, Moore MJ, Thibodeau
SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R,
Shepherd LE, et al: Tumor microsatellite-instability status as a
predictor of benefit from fluorouracil-based adjuvant chemotherapy
for colon cancer. N Engl J Med. 349:247–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boland CR, Thibodeau SN, Hamilton SR,
Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA,
Fodde R, Ranzani GN, et al: A National Cancer Institute Workshop on
Microsatellite Instability for cancer detection and familial
predisposition: development of international criteria for the
determination of microsatellite instability in colorectal cancer.
Cancer Res. 58:5248–5257. 1998.PubMed/NCBI
|
|
29
|
Cunningham JM, Kim CY, Christensen ER,
Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ,
Vockley C Walsh, et al: The frequency of hereditary defective
mismatch repair in a prospective series of unselected colorectal
carcinomas. Am J Hum Genet. 69:780–790. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rustgi AK: The genetics of hereditary
colon cancer. Genes Dev. 21:2525–2538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peltomäki P and Vasen H: Mutations
associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT
mutation database. Dis Markers. 20:269–276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Plaschke J, Engel C, Krüger S,
Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann
K, Gebert J, von Knebel Doeberitz M, et al: Lower incidence of
colorectal cancer and later age of disease onset in 27 families
with pathogenic MSH6 germline mutations compared with families with
MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis
Colorectal Cancer Consortium. J Clin Oncol. 22:4486–4494. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Senter L, Clendenning M, Sotamaa K, Hampel
H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN,
Lindor NM, et al: The clinical phenotype of Lynch syndrome due to
germ-line PMS2 mutations. Gastroenterology. 135:419–428. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bülow S: Familial polyposis coli. Dan Med
Bull. 34:1–15. 1987.
|
|
35
|
Giardiello FM, Brensinger JD and Petersen
GM: AGA technical review on hereditary colorectal cancer and
genetic testing. Gastroenterology. 121:198–213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soravia C, Berk T, McLeod RS and Cohen Z:
Desmoid disease in patients with familial adenomatous polyposis.
Dis Colon Rectum. 43:363–369. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Belchetz LA, Berk T, Bapat BV, Cohen Z and
Gallinger S: Changing causes of mortality in patients with familial
adenomatous polyposis. Dis Colon Rectum. 39:384–387. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cetta F, Montalto G, Gori M, Curia MC,
Cama A and Olschwang S: Germline mutations of the APC gene in
patients with familial adenomatous polyposis-associated thyroid
carcinoma: results from a European cooperative study. J Clin
Endocrinol Metab. 85:286–92. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kinzler KW and Vogelstein B: Lessons from
hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bisgaard ML, Fenger K, Bülow S, Niebuhr E
and Mohr J: Familial adenomatous polyposis (FAP): frequency,
penetrance, and mutation rate. Hum Mutat. 3:121–125. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hes FJ, Nielsen M, Bik EC, Konvalinka D,
Wijnen JT, Bakker E, Vasen HF, Breuning MH and Tops CM: Somatic APC
mosaicism: an underestimated cause of polyposis coli. Gut.
57:71–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nieuwenhuis MH and Vasen HF: Correlations
between mutation site in APC and phenotype of familial adenomatous
polyposis (FAP): a review of the literature. Crit Rev Oncol
Hematol. 61:153–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Galiatsatos P and Foulkes WD: Familial
adenomatous polyposis. Am J Gastroenterol. 101:385–398. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Laken SJ, Petersen GM, Gruber SB, Oddoux
C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A,
Klimstra D, et al: Familial colorectal cancer in Ashkenazim due to
a hypermutable tract in APC. Nat Genet. 17:79–83. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gryfe R, Di Nicola N, Lal G, Gallinger S
and Redston M: Inherited colorectal polyposis and cancer risk of
the APC I1307K polymorphism. Am J Hum Genet. 64:378–384. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Claes K, Dahan K, Tejpar S, De Paepe A,
Bonduelle M, Abramowicz M, Verellen C, Franchimont D, Van Cutsem E
and Kartheuser A: The genetics of familial adenomatous polyposis
(FAP) and MutYH-associated polyposis (MAP). Acta Gastroenterol
Belg. 74:421–426. 2011.PubMed/NCBI
|
|
48
|
Al-Tassan N, Chmiel NH, Maynard J, Fleming
N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS,
Sampson JR, et al: Inherited variants of MYH associated with
somatic G:C->T:A mutations in colorectal tumors. Nat Genet.
30:227–232. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lefevre JH, Parc Y, Svrcek M, Kernéis S,
Colas C, Shields C, Flejou JF, Parc R and Tiret E: APC, MYH, and
the correlation genotype-phenotype in colorectal polyposis. Ann
Surg Oncol. 16:871–877. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Morak M, Laner A, Bacher U, Keiling C and
Holinski-Feder E: MUTYH-associated polyposis - variability of the
clinical phenotype in patients with biallelic and monoallelic MUTYH
mutations and report on novel mutations. Clin Genet. 78:353–363.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Out AA, Tops CM, Nielsen M, Weiss MM, van
Minderhout IJ, Fokkema IF, Buisine MP, Claes K, Colas C, Fodde R,
et al: Leiden open variation database of the MUTYH gene. Hum Mutat.
31:1205–1215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cleary SP, Cotterchio M, Jenkins MA, Kim
H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N,
et al: Germline MutY human homologue mutations and colorectal
cancer: a multisite case-control study. Gastroenterology.
136:1251–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nielsen M, Joerink-van de Beld MC, Jones
N, Vogt S, Tops CM, Vasen HF, Sampson JR, Aretz S and Hes FJ:
Analysis of MUTYH genotypes and colorectal phenotypes in patients
with MUTYH-associated polyposis. Gastroenterology. 136:471–476.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sieber OM, Lipton L, Crabtree M, Heinimann
K, Fidalgo P, Phillips RK, Bisgaard ML, Orntoft TF, Aaltonen LA,
Hodgson SV, et al: Multiple colorectal adenomas, classic
adenomatous polyposis, and germ-line mutations in MYH. N Engl J
Med. 348:791–799. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lipton L and Tomlinson I: The multiple
colorectal adenoma phenotype and MYH, a base excision repair gene.
Clin Gastroenterol Hepatol. 2:633–638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Halford SE, Rowan AJ, Lipton L, Sieber OM,
Pack K, Thomas HJ, Hodgson SV, Bodmer WF and Tomlinson IP: Germline
mutations but not somatic changes at the MYH locus contribute to
the pathogenesis of unselected colorectal cancers. Am J Pathol.
162:1545–1548. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Nielsen M, Morreau H, Vasen HF and Hes FJ:
MUTYH-associated polyposis (MAP). Crit Rev Oncol Hematol. 79:1–16.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jones S, Emmerson P, Maynard J, Best JM,
Jordan S, Williams GT, Sampson JR and Cheadle JP: Biallelic
germline mutations in MYH predispose to multiple colorectal adenoma
and somatic G:C->T:A mutations. Hum Mol Genet. 11:2961–2967.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sampson JR, Dolwani S, Jones S, Eccles D,
Ellis A, Evans DG, Frayling I, Jordan S, Maher ER, Mak T, et al:
Autosomal recessive colorectal adenomatous polyposis due to
inherited mutations of MYH. Lancet. 362:39–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Enholm S, Hienonen T, Suomalainen A,
Lipton L, Tomlinson I, Kärjä V, Eskelinen M, Mecklin JP, Karhu A,
Järvinen HJ, et al: Proportion and phenotype of MYH-associated
colorectal neoplasia in a population-based series of Finnish
colorectal cancer patients. Am J Pathol. 163:827–832. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang L, Baudhuin LM, Boardman LA,
Steenblock KJ, Petersen GM, Halling KC, French AJ, Johnson RA,
Burgart LJ, Rabe K, et al: MYH mutations in patients with
attenuated and classic polyposis and with young-onset colorectal
cancer without polyps. Gastroenterology. 127:9–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jo WS, Bandipalliam P, Shannon KM,
Niendorf KB, Chan-Smutko G, Hur C, Syngal S and Chung DC:
Correlation of polyp number and family history of colon cancer with
germline MYH mutations. Clin Gastroenterol Hepatol. 3:1022–1028.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Venesio T, Molatore S, Cattaneo F,
Arrigoni A, Risio M and Ranzani GN: High frequency of MYH gene
mutations in a subset of patients with familial adenomatous
polyposis. Gastroenterology. 126:1681–1685. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Knopperts AP, Nielsen M, Niessen RC, Tops
CM, Jorritsma B, Varkevisser J, Wijnen J, Siezen CL, Heine-Bröring
RC, van Kranen HJ, et al: Contribution of bi-allelic germline MUTYH
mutations to early-onset and familial colorectal cancer and to low
number of adenomatous polyps: case-series and literature review.
Fam Cancer. 12:43–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Filipe B, Baltazar C, Albuquerque C,
Fragoso S, Lage P, Vitoriano I, Mão de Ferro S, Claro I, Rodrigues
P, Fidalgo P, et al: APC or MUTYH mutations account for the
majority of clinically well-characterized families with FAP and
AFAP phenotype and patients with more than 30 adenomas. Clin Genet.
76:242–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Palles C, Cazier JB, Howarth KM, Domingo
E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I,
et al: WGS500 Consortium: Germline mutations affecting the
proofreading domains of POLE and POLD1 predispose to colorectal
adenomas and carcinomas. Nat Genet. 45:136–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Valle L, Hernández-Illán E, Bellido F,
Aiza G, Castillejo A, Castillejo MI, Navarro M, Seguí N, Vargas G,
Guarinos C, et al: New insights into POLE and POLD1 germline
mutations in familial colorectal cancer and polyposis. Hum Mol
Genet. 23:3506–3512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jenne DE, Reimann H, Nezu J, Friedel W,
Loff S, Jeschke R, Müller O, Back W and Zimmer M: Peutz-Jeghers
syndrome is caused by mutations in a novel serine threonine kinase.
Nat Genet. 18:38–43. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Donehower LA, Creighton CJ, Schultz N,
Shinbrot E, Chang K, Gunaratne PH, Muzny D, Sander C, Hamilton SR,
Gibbs RA, et al: MLH1-silenced and non-silenced subgroups of
hypermutated colorectal carcinomas have distinct mutational
landscapes. J Pathol. 229:99–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Church DN, Briggs SE, Palles C, Domingo E,
Kearsey SJ, Grimes JM, Gorman M, Martin L, Howarth KM, Hodgson SV,
et al: NSECG Collaborators: DNA polymerase ε and δ exonuclease
domain mutations in endometrial cancer. Hum Mol Genet.
22:2820–2828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Briggs S and Tomlinson I: Germline and
somatic polymerase ε and δ mutations define a new class of
hypermutated colorectal and endometrial cancers. J Pathol.
230:148–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Schreibman IR, Baker M, Amos C and
McGarrity TJ: The hamartomatous polyposis syndromes: a clinical and
molecular review. Am J Gastroenterol. 100:476–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
McGarrity TJ and Amos C: Peutz-Jeghers
syndrome: clinicopathology and molecular alterations. Cell Mol Life
Sci. 63:2135–2144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gammon A, Jasperson K, Kohlmann W and Burt
RW: Hamartomatous polyposis syndromes. Best Pract Res Clin
Gastroenterol. 23:219–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chow E and Macrae F: A review of juvenile
polyposis syndrome. J Gastroenterol Hepatol. 20:1634–1640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Boardman LA: Heritable colorectal cancer
syndromes: recognition and preventive management. Gastroenterol
Clin North Am. 31:1107–1131. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Latchford AR, Neale K, Phillips RK and
Clark SK: Juvenile polyposis syndrome: a study of genotype,
phenotype, and long-term outcome. Dis Colon Rectum. 55:1038–1043.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Howe JR, Bair JL, Sayed MG, Anderson ME,
Mitros FA, Petersen GM, Velculescu VE, Traverso G and Vogelstein B:
Germline mutations of the gene encoding bone morphogenetic protein
receptor 1A in juvenile polyposis. Nat Genet. 28:184–187. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Howe JR, Ringold JC, Summers RW, Mitros
FA, Nishimura DY and Stone EM: A gene for familial juvenile
polyposis maps to chromosome 18q21.1. Am J Hum Genet. 62:1129–1136.
1998. View
Article : Google Scholar : PubMed/NCBI
|
|
80
|
Howe JR, Roth S, Ringold JC, Summers RW,
Järvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros
FA, et al: Mutations in the SMAD4/DPC4 gene in juvenile polyposis.
Science. 280:1086–1088. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhou XP, Woodford-Richens K, Lehtonen R,
Kurose K, Aldred M, Hampel H, Launonen V, Virta S, Pilarski R,
Salovaara R, et al: Germline mutations in BMPR1A/ALK3 cause a
subset of cases of juvenile polyposis syndrome and of Cowden and
Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet. 69:704–711.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
82
|
Aretz S, Stienen D, Uhlhaas S, Stolte M,
Entius MM, Loff S, Back W, Kaufmann A, Keller KM, Blaas SH, et al:
High proportion of large genomic deletions and a genotype phenotype
update in 80 unrelated families with juvenile polyposis syndrome. J
Med Genet. 44:702–709. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sayed MG, Ahmed AF, Ringold JR, Anderson
ME, Bair JL, Mitros FA, Lynch HT, Tinley ST, Petersen GM,
Giardiello FM, et al: Germline SMAD4 or BMPR1A mutations and
phenotype of juvenile polyposis. Ann Surg Oncol. 9:901–906. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Howe JR, Sayed MG, Ahmed AF, Ringold J,
Larsen-Haidle J, Merg A, Mitros FA, Vaccaro CA, Petersen GM,
Giardiello FM, et al: The prevalence of MADH4 and BMPR1A mutations
in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1
mutations. J Med Genet. 41:484–491. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Friedl W, Uhlhaas S, Schulmann K, Stolte
M, Loff S, Back W, Mangold E, Stern M, Knaebel HP, Sutter C, et al:
Juvenile polyposis: massive gastric polyposis is more common in
MADH4 mutation carriers than in BMPR1A mutation carriers. Hum
Genet. 111:108–111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Handra-Luca A, Condroyer C, de Moncuit C,
Tepper M, Fléjou JF, Thomas G and Olschwang S: Vessels' morphology
in SMAD4 and BMPR1A-related juvenile polyposis. Am J Med Genet A
138A. 113–117. 2005. View Article : Google Scholar
|
|
87
|
O'Malley M, LaGuardia L, Kalady MF,
Parambil J, Heald B, Eng C, Church J and Burke CA: The prevalence
of hereditary hemorrhagic telangiectasia in juvenile polyposis
syndrome. Dis Colon Rectum. 55:886–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sweet K, Willis J, Zhou XP, Gallione C,
Sawada T, Alhopuro P, Khoo SK, Patocs A, Martin C, Bridgeman S, et
al: Molecular classification of patients with unexplained
hamartomatous and hyperplastic polyposis. JAMA. 294:2465–2473.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
van Hattem WA, Brosens LA, de Leng WW,
Morsink FH, Lens S, Carvalho R, Giardiello FM and Offerhaus GJ:
Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile
polyposis. Gut. 57:623–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Eng C and Ji H: Molecular classification
of the inherited hamartoma polyposis syndromes: clearing the
muddied waters. Am J Hum Genet. 62:1020–1022. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Dahdaleh FS, Carr JC, Calva D and Howe JR:
Juvenile polyposis and other intestinal polyposis syndromes with
microdeletions of chromosome 10q22-23. Clin Genet. 81:110–116.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Starink TM, van der Veen JP, Arwert F, de
Waal LP, de Lange GG, Gille JJ and Eriksson AW: The Cowden
syndrome: a clinical and genetic study in 21 patients. Clin Genet.
29:222–233. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Heald B, Mester J, Rybicki L, Orloff MS,
Burke CA and Eng C: Frequent gastrointestinal polyps and colorectal
adenocarcinomas in a prospective series of PTEN mutation carriers.
Gastroenterology. 139:1927–1933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Stanich PP, Owens VL, Sweetser S,
Khambatta S, Smyrk TC, Richardson RL, Goetz MP and Patnaik MM:
Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc.
86:489–492. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Trufant JW, Greene L, Cook DL, McKinnon W,
Greenblatt M and Bosenberg MW: Colonic ganglioneuromatous polyposis
and metastatic adenocarcinoma in the setting of Cowden syndrome: a
case report and literature review. Hum Pathol. 43:601–604. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Levi Z, Baris HN, Kedar I, Niv Y, Geller
A, Gal E, Gingold R, Morgenstern S, Baruch Y, Leach BH, et al:
Upper and lower gastrointestinal findings in pten mutation-positive
cowden syndrome patients participating in an active surveillance
program. Clin Transl Gastroenterol. 2:e52011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Pilarski R: Cowden syndrome: a critical
review of the clinical literature. J Genet Couns. 18:13–27. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
McGarrity TJ, Baker MJ Wagner, Ruggiero
FM, Thiboutot DM, Hampel H, Zhou XP and Eng C: GI polyposis and
glycogenic acanthosis of the esophagus associated with PTEN
mutation positive Cowden syndrome in the absence of cutaneous
manifestations. Am J Gastroenterol. 98:1429–1434. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI,
Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, et al: Germline
mutations of the PTEN gene in Cowden disease, an inherited breast
and thyroid cancer syndrome. Nat Genet. 16:64–67. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Nelen MR, Padberg GW, Peeters EA, Lin AY,
van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM,
Easton DF, et al: Localization of the gene for Cowden disease to
chromosome 10q22-23. Nat Genet. 13:114–116. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Nelen MR, van Staveren WC, Peeters EA,
Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH,
Woods DG, et al: Germline mutations in the PTEN/MMAC1 gene in
patients with Cowden disease. Hum Mol Genet. 6:1383–1387. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lynch ED, Ostermeyer EA, Lee MK, Arena JF,
Ji H, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, et
al: Inherited mutations in PTEN that are associated with breast
cancer, cowden disease, and juvenile polyposis. Am J Hum Genet.
61:1254–1260. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
103
|
Stambolic V, Suzuki A, de la Pompa JL,
Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM,
Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent
cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Kalady MF, Jarrar A, Leach B, LaGuardia L,
O'Malley M, Eng C and Church JM: Defining phenotypes and cancer
risk in hyperplastic polyposis syndrome. Dis Colon Rectum.
54:164–170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Carvajal-Carmona LG, Howarth KM, Lockett
M, Polanco-Echeverry GM, Volikos E, Gorman M, Barclay E, Martin L,
Jones AM, Saunders B, et al: Molecular classification and genetic
pathways in hyperplastic polyposis syndrome. J Pathol. 212:378–385.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Buchanan DD, Sweet K, Drini M, Jenkins MA,
Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters
RJ, et al: Risk factors for colorectal cancer in patients with
multiple serrated polyps: a cross-sectional case series from
genetics clinics. PLoS One. 5:e116362010. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Buchanan DD, Sweet K, Drini M, Jenkins MA,
Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, et
al: Phenotypic diversity in patients with multiple serrated polyps:
a genetics clinic study. Int J Colorectal Dis. 25:703–712. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Chow E, Lipton L, Lynch E, D'Souza R,
Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, et
al: Hyperplastic polyposis syndrome: phenotypic presentations and
the role of MBD4 and MYH. Gastroenterology. 131:30–39. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Young J and Jass JR: The case for a
genetic predisposition to serrated neoplasia in the colorectum:
hypothesis and review of the literature. Cancer Epidemiol
Biomarkers Prev. 15:1778–1784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Boparai KS, Dekker E, Van Eeden S, Polak
MM, Bartelsman JF, Mathus-Vliegen EM, Keller JJ and van Noesel CJ:
Hyperplastic polyps and sessile serrated adenomas as a phenotypic
expression of MYH-associated polyposis. Gastroenterology.
135:2014–2018. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Mongin C, Coulet F, Lefevre JH, Colas C,
Svrcek M, Eyries M, Lahely Y, Fléjou JF, Soubrier F and Parc Y:
Unexplained polyposis: a challenge for geneticists, pathologists
and gastroenterologists. Clin Genet. 81:38–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Clendenning M, Young JP, Walsh MD, Woodall
S, Arnold J, Jenkins M, Win AK, Hopper JL, Sweet K, Gallinger S, et
al: Germline mutations in the polyposis-associated genes, and are
not common in individuals with serrated polyposis syndrome. PLoS
One. 8:e667052013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Rebours V, Boutron-Ruault MC, Schnee M,
Férec C, Maire F, Hammel P, Ruszniewski P and Lévy P: Risk of
pancreatic adenocarcinoma in patients with hereditary pancreatitis:
a national exhaustive series. Am J Gastroenterol. 103:111–119.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Greer JB, Whitcomb DC and Brand RE:
Genetic predisposition to pancreatic cancer: a brief review. Am J
Gastroenterol. 102:2564–2569. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Goggins M, Schutte M, Lu J, Moskaluk CA,
Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH,
et al: Germline BRCA2 gene mutations in patients with apparently
sporadic pancreatic carcinomas. Cancer Res. 56:5360–5364.
1996.PubMed/NCBI
|
|
116
|
Chapman PB: Melanoma vaccines. Semin
Oncol. 34:516–523. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Pogue-Geile KL, Chen R, Bronner MP,
Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA,
George RD, Whitcomb DC, et al: Palladin mutation causes familial
pancreatic cancer and suggests a new cancer mechanism. PLoS Med.
3:e5162006. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Roberts NJ, Jiao Y, Yu J, Kopelovich L,
Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML,
et al: ATM mutations in patients with hereditary pancreatic cancer.
Cancer Discov. 2:41–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Harinck F, Kluijt I, van Mil SE, Waisfisz
Q, van Os TA, Aalfs CM, Wagner A, Olderode-Berends M, Sijmons RH,
Kuipers EJ, et al: Routine testing for PALB2 mutations in familial
pancreatic cancer families and breast cancer families with
pancreatic cancer is not indicated. Eur J Hum Genet. 20:577–579.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Jones S, Hruban RH, Kamiyama M, Borges M,
Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, et
al: Exomic sequencing identifies PALB2 as a pancreatic cancer
susceptibility gene. Science. 324:2172009. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Huntsman DG, Carneiro F, Lewis FR, MacLeod
PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE and
Caldas C: Early gastric cancer in young, asymptomatic carriers of
germ-line E-cadherin mutations. N Engl J Med. 344:1904–1909. 2001.
View Article : Google Scholar : PubMed/NCBI
|
